Which has the lower trailing P/E, HSIC or UHS?

UHS has the lower trailing P/E: HSIC trades at 26.61 and UHS at 7.09. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, HSIC or UHS?

Over the past five years, UHS grew revenue faster — HSIC at a 4.74% CAGR versus UHS at 8.21%.

Does HSIC or UHS pay a bigger dividend?

UHS pays a dividend (0.46% yield), while HSIC has no payments in the available dividend history.

Is HSIC or UHS more profitable?

UHS runs the higher net margin — HSIC at 2.95% versus UHS at 8.42%.

How have HSIC and UHS total returns compared?

Over the past 10 years, HSIC delivered 3.06% and UHS delivered 3.63% annualized total return. Past performance doesn't predict future results.

Henry Schein, Inc. (HSIC) vs Universal Health Services, Inc. (UHS)

A side-by-side comparison of Henry Schein, Inc. and Universal Health Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 11, 2026. Differences are shown without an overall score or investment verdict.

HSIC

Henry Schein, Inc.

$10.16B

$89.18HealthcareDelayed quote: Aug 11, 2026, 4:00 PM EDT

UHS

Universal Health Services, Inc.

$10.21B

$168.72HealthcareDelayed quote: Aug 11, 2026, 4:00 PM EDT

Total return — HSIC vs UHS

growth of $100 · dividends reinvested · last 10y

HSIC +39.2% (+3.4%/yr)UHS +43.0% (+3.6%/yr)UHS compounded faster over this window

HSIC UHS

HSIC vs UHS: by the numbers

•UHS is the larger company ($10.21B vs $10.16B market cap).
•UHS trades at the lower trailing earnings multiple (7.09 vs 26.61 P/E), one valuation lens rather than an overall verdict.
•UHS converts more revenue to profit (8.42% vs 2.95% net margin).
•UHS grew revenue faster over the past five years (8.21% vs 4.74% CAGR).
•UHS pays a dividend (0.46% yield), while HSIC has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	HSIC	UHS
P/E ratio	26.61	7.09
Forward P/E	16.37	7.63
P/S ratio	0.76	0.57
P/B ratio	3.13	1.38
EV / EBITDA	13.12	5.73
FCF yield	4.22%	7.99%

Profitability

Metric	HSIC	UHS
Gross margin	29.69%	90.69%
Operating margin	5.60%	11.36%
Net margin	2.95%	8.42%
ROE	12.09%	20.31%
ROIC	6.58%	11.29%

Dividends

Metric	HSIC	UHS
Dividend yield	N/A	0.46%
Payout ratio	N/A	3.42%

Growth (annualized)

Metric	HSIC	UHS
Revenue CAGR (5Y)	4.74%	8.21%
EPS CAGR (5Y)	3.14%	16.19%
FCF CAGR (5Y)	0.82%	-12.18%
Total return CAGR (5Y)	3.12%	3.81%

Frequently asked

Which has the lower trailing P/E, HSIC or UHS?: UHS has the lower trailing P/E: HSIC trades at 26.61 and UHS at 7.09. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, HSIC or UHS?: Over the past five years, UHS grew revenue faster — HSIC at a 4.74% CAGR versus UHS at 8.21%.
Does HSIC or UHS pay a bigger dividend?: UHS pays a dividend (0.46% yield), while HSIC has no payments in the available dividend history.
Is HSIC or UHS more profitable?: UHS runs the higher net margin — HSIC at 2.95% versus UHS at 8.42%.
How have HSIC and UHS total returns compared?: Over the past 10 years, HSIC delivered 3.06% and UHS delivered 3.63% annualized total return. Past performance doesn't predict future results.

Go deeper

Full HSIC analysis Full UHS analysis Interactive comparison tool

Dig into the metrics

Henry Schein P/E ratio Universal Health Services P/E ratio Universal Health Services dividend yield Henry Schein ROE Universal Health Services ROE Henry Schein operating margin Universal Health Services operating margin Henry Schein revenue growth Universal Health Services revenue growth Henry Schein free cash flow Universal Health Services free cash flow

Henry Schein & Universal Health Services appear in these rankings

Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 11, 2026.